Iopamiro (Iopamidol)

• Iopamiro, an iodinated contrast agent, is used in radiographic procedures that require enhanced visualization of vascular and body cavity structures.
• Angiography: improves delineation of blood vessels for diagnostic and interventional purposes.
• Arthrography: enhances joint space imaging to assess cartilage, ligaments, and intra‑articular pathology.
• Myelography: provides contrast for spinal canal evaluation, aiding detection of spinal lesions and nerve root compression.

• Iopamidol is a non‑ionic, water‑soluble iodine‑containing compound that, when injected, increases the X‑ray attenuation of blood vessels, organs, and body cavities. The high atomic number of iodine absorbs X‑ray photons, creating a temporary contrast difference between the enhanced structures and surrounding tissues, thereby improving image clarity during radiographic examinations.

Iopamiro may cause a range of adverse reactions following administration.

Common Side Effects

• Warmth or flushing sensation during injection.
• Metallic taste or mild nausea.
• Transient headache.
• Mild urticaria or skin itching.
• Temporary increase in blood pressure.
• Mild vomiting.

Serious or Rare Side Effects

• Severe allergic reaction or anaphylaxis.
• Acute renal impairment, especially in patients with pre‑existing kidney disease.
• Seizures or neurological disturbances.
• Hypotension or cardiovascular collapse.
• Cardiac arrest.
• Pulmonary edema.

Before using Iopamiro, clinicians should consider several safety measures.

• Assess renal function: evaluate serum creatinine and eGFR.
• Review allergy history: identify prior iodine or contrast media reactions.
• Use the lowest effective dose for the specific imaging study.
• Monitor vital signs and patient response during and after injection.
• Avoid in patients with known severe hypersensitivity to iodinated contrast agents.
• Store at ambient temperature: keep in the original container, protect from moisture and direct light.

Iopamiro can interact with other medications, requiring careful management.

Major Interactions (Avoid)

• Metformin: increased risk of lactic acidosis in renal impairment.
• Thyroid hormone therapy: excessive iodine load may affect thyroid function.
• ACE inhibitors: heightened risk of contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely)

• Diuretics: may exacerbate fluid and electrolyte imbalances.
• NSAIDs: combined renal toxicity potential.
• Beta‑blockers: possible hemodynamic alterations during contrast administration.